Musk: Neuralink Trials Success, Mind Mouse Control

Elon Musk Announces Successful Brain-Computer Interface Experiment

On February 20th, according to reports from the media, Tesla’s CEO Elon Musk revealed on the social media platform X that the first human trial participant of Neuralink, the brain-machine interface company, “seems to have fully recovered and is able to move a computer mouse on the screen using only their thoughts”.

Previously, Neuralink had conducted chip implant experiments on monkeys and received approval from the U.S. Food and Drug Administration, officially commencing the first clinical trials of brain implant devices.

Based on previous recruitment information, patients paralyzed due to spinal cord injuries or amyotrophic lateral sclerosis (ALS) are eligible to participate in the clinical trials.

It is reported that this human trial will last for six years, where participants will initially engage in an 18-month study, followed by at least two hours of brain-machine interface research every week.

Established in 2016, Neuralink aims to establish a communication channel between the human brain and external devices by implanting ultra-fine wires in the brain, connecting these threads to a custom-designed chip that contains electrodes capable of reading neuronal group information.

Reports suggest that thousands of people are already in line to receive Neuralink’s brain implant device, and Neuralink plans to implant chips in over 22,000 individuals by 2030.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.